
Vandaniya Medicaments Private Limited
About Vandaniya Medicaments Private Limited
Data last updated:
Vandaniya Medicaments Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 10 March 2022.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24110MH2022PTC378285.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Piyush Goyal and Meena Rashmi Bhayani.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot C1 Flat – 503 Floor 5 Wing – A Anshul Plaza Chs Ltd Link Road, Mumbai, Maharashtra, India – 400067.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.98 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹5.43 Lakh (net margin 2.7%) and EBITDA of ₹11.08 Lakh (EBITDA margin 5.6%).
Company details
Contact details
Vandaniya Medicaments Private Limited's registered office is in Mumbai, Maharashtra.
- Registered AddressPlot C1 Flat – 503 Floor 5 Wing – A Anshul Plaza Chs Ltd Link Road, Mumbai, Maharashtra, India – 400067
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Vandaniya Medicaments is human health and social work activities. In detail, this covers human health activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Human health and social work activities | 86 | Human health activities |
To see the full business activity and turnover split of Vandaniya Medicaments Private Limited, buy the company report.
Financials of Vandaniya Medicaments Private Limited
FY 2025 filings availableVandaniya Medicaments Private Limited reported revenue of ₹1.98 Cr (up 198% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 198% in the latest year. EBITDA rose 526% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹11.08 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹5.43 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 5.6% | |||
| Net Profit Margin | 2.7% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Vandaniya Medicaments Private Limited, buy the company report.
Board of directors of Vandaniya Medicaments Private Limited
Vandaniya Medicaments has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Piyush Goyal | Director | 10 Mar 2022 | 4 Years 8 Months | Current |
| Meena Rashmi Bhayani | Director | 10 Mar 2022 | 4 Years 8 Months | Current |
Peer comparison
Vandaniya Medicaments Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (human health activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Hyma Hospitals Pvt Ltd | ₹1.99 Cr (FY 2025) | 2.0% | Andhra Pradesh, India | |||
| Resplice Private Limited | ₹1.99 Cr (FY 2025) | Hyderabad, Telangana, India | ||||
| Magnet Healthcare and Diagnostics Private Limited | ₹1.99 Cr (FY 2025) | -16.0% | Mumbai, Maharashtra, India | |||
| Matrika Manjula Nursing Home Private Limited | ₹1.98 Cr (FY 2025) | 36.0% | Samastipur, Bihar, India | |||
| Forbes Healthcare Foundation | ₹1.98 Cr (FY 2025) | -8.0% | Pune, Maharashtra, India | |||
| Vandaniya Medicaments Private Limitedthis company | ₹1.98 Cr (FY 2025) | ₹5.43 Lakh | 2.7% | 198.0% | Mumbai, Maharashtra, India | |
| Anupam Eye Hospital and Research Centre Private Limited | ₹1.98 Cr (FY 2025) | 11.0% | Jaipur, Rajasthan, India | |||
| United Diagnostics and Imaging Centre Private Limited | ₹1.98 Cr (FY 2024) | 304.0% | Azamgarh, Uttar Pradesh, India | |||
| Healthswift Solutions Private Limited | ₹1.98 Cr (FY 2025) | 801.0% | Barasat, West Bengal, India | |||
| Bandyopadhyay Healthcare Private Limited | ₹1.98 Cr (FY 2024) | 13.0% | Bankura, West Bengal, India | |||
| Sanitas Care Private Limited | ₹1.97 Cr (FY 2025) | 21.0% | Ujjain, Madhya Pradesh, India |
To see the full peer comparison of Vandaniya Medicaments Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Vandaniya Medicaments Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Vandaniya Medicaments Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Vandaniya Medicaments Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Vandaniya Medicaments Private Limited has 3 board changes on record since 2022: 2 appointments and 1 cessation. The latest: Shiv Shankar Vijay ceased to be Director on 02 Aug 2024.
Frequently asked questions
Vandaniya Medicaments is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 10 March 2022 (4+ years old) and is registered under CIN U24110MH2022PTC378285.
Vandaniya Medicaments has 2 current directors:
- Piyush Goyal - Director
- Meena Rashmi Bhayani - Director
The latest financial statements of Vandaniya Medicaments on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Vandaniya Medicaments is U24110MH2022PTC378285. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Vandaniya Medicaments was incorporated on 10 March 2022, making it 4+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Vandaniya Medicaments by revenue are Hyma Hospitals Pvt Ltd, Resplice Private Limited, Magnet Healthcare and Diagnostics Private Limited, Matrika Manjula Nursing Home Private Limited, Forbes Healthcare Foundation and 5 more, all in the same principal business activity (human health activities).
Shiv Shankar Vijay ceased to be Director on 02 Aug 2024. Meena Rashmi Bhayani was appointed as Director on 10 Mar 2022. Piyush Goyal was appointed as Director on 10 Mar 2022.
The registered office of Vandaniya Medicaments is at Plot C1 Flat – 503 Floor 5 Wing – A Anshul Plaza Chs Ltd Link Road, Mumbai, Maharashtra, India – 400067.
Vandaniya Medicaments operates in the pharma industry, in the drug formulation and development segment.
Vandaniya Medicaments can be reached at its registered office: Plot C1 Flat – 503 Floor 5 Wing – A Anshul Plaza Chs Ltd Link Road, Mumbai, Maharashtra, India – 400067.
Vandaniya Medicaments is registered under the jurisdiction of the Registrar of Companies (ROC), Mumbai.

